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Abstract
Chromatin immunoprecipitation followed by high-throughput (HTP) sequencing (ChIP-seq) is a powerful tool to establish
protein-DNA interactions genome-wide. The primary limitation of its broad application at present is the often-limited access
to sequencers. Here we report a protocol, Mab-seq, that generates genome-scale quality evaluations for nucleic acid
libraries intended for deep-sequencing. We show how commercially available genomic microarrays can be used to
maximize the efficiency of library creation and quickly generate reliable preliminary data on a chromosomal scale in advance
of deep sequencing. We also exploit this technique to compare enriched regions identified using microarrays with those
identified by sequencing, demonstrating that they agree on a core set of clearly identified enriched regions, while
characterizing the additional enriched regions identifiable using HTP sequencing.
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Introduction
Chromatin immunoprecipitation (ChIP) is widely used to
identify interactions between genomic DNA and proteins in
eukaryotic cells [1]. Recent approaches have identified transcrip-
tion factor binding or histone modifications by combining ChIP
experiments with genomic-tiling or promoter-based microarrays
(i.e. ChIP-chip) [2–9]. The subsequent maps of transcription factor
binding, chromatin structure, and modifications established by
ChIP-chip and similar assays have greatly broadened our
understanding of mechanisms regulating transcription [2–9].
However, microarrays generally interrogate only genomic regions
rich in unique sequences, and their designs typically start by
eliminating half of a mammalian genome due to repeat regions.
The application of high-throughput (HTP) DNA sequencing to
ChIP experiments (ChIP-seq) has overcome many microarray-
related limitations in probe coverage and resolution [10–13].
ChIP-seq allows transcription factor and histone patterning of
complex mammalian genomes to be identified at high resolution,
and the interrogation of virtually an entire mammalian genome is
now possible. As HTP sequencing technology can be difficult to
access and expensive to use, a method to inspect sequencing
library quality and genomic enrichment for ChIP-seq experiments
in advance of deep sequencing would be of substantial utility to a
wide number of researchers [14].
Here we report such a methodology (Microarrays-before-
Sequencing, Mab-seq), which should also be of interest to
investigatorsusing chromatinimmunoprecipitations who are working
primarily with microarrays, but wish to bank material for later
genome-wide interrogations. This method also offers advantages to
investigators with access to HTP instruments (e.g. Illumina Genome
Analyzer) who wish to test their libraries prior to sequencing without
compromising either experimental approach by sample loss.
Results and Discussion
Adaptation of sequencing libraries for preliminary
microarray hybridization
We developed Microarray-before-sequencing (Mab-seq) for use in
ChIP experiments with both transcription factor binding and
chromatin modification assays. We modified DNA library prepara-
tion for the Illumina Genome Analyzer to allow the small amounts of
ChIP-enriched DNA to be simultaneously used on both commer-
cially available microarrays and Illumina sequencers (Figure 1A).
This methodology was demonstrated by performing ChIP on
hepatocytes isolated directly from mouse liver using well-character-
ized antisera against the liver-enriched transcription factor Hnf4a
[6,7,15] and the trimethylated lysine 4 of histone H3 [2,3,5,12].
Because sequence-specific transcription factor ChIPs from primary
tissue often show lower enrichment than ChIPs against more general
factors such as RNA polymerase II or histone modifications, the use
of Hnf4a was an important inclusion in our protocol development.
We remove a small portion of the library preparations and then
amplify these aliquots using standard techniques. This material is
then labeled with fluorophores, and can be hybridized to any
commercially available array. Below, we demonstrate this protocol
for ChIP enrichment using mouse chromosome 16 tiling
microarrays (Agilent Technologies), followed by subsequent deep
sequencing using an Illumina/Solexa 1G Genome Analyzer. This
approach can be used with other commercial microarray
platforms (Nimblegen, Affymetrix, or self-print microarrays).
Microarrays accurately predict ChIP enriched regions in
HTP sequencing libraries
Comparing microarray probe enrichment to sequencing read
depth for the same sample reveals a high degree of correspondence
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3713(Figure 1B). Computational identification of enriched regions
(enriched regions: ERs, see Methods) confirms this correspondence.
Using microarrays, 198 regions were identified as enriched in
trimethylation of the lysine 4 position of histone H3 (H3K4me3), of
which 191 were also identified by subsequent sequencing (Figure 1C).
For the transcription factor Hnf4a, 83 of the 86 ERs present on the
microarrays were subsequently identified also by sequencing analysis.
Only three Hnf4a microarray bound regions and seven histone-
marked regions identified by microarray analysis were not subse-
quently identified using the corresponding ChIP-seq data.
Rank ordering of the complete set of bound genomic regions
detected by the microarrays versus regions identified as bound by
ChIP-seq showed high overlap (Figure 2A, black line). Even
modest sequencing of these libraries largely recapitulated micro-
array results, though Hnf4a shows stronger dependence on depth
of sequencing. This dependence appears to be a function of both
the narrower region of enrichment found for transcription factors,
as well as the lower enrichment for site-specific transcription
factors compared to histone mark enrichment. Thus, a sequencing
library created from a chromatin immunoprecipitation can be
labeled and hybridized to a genomic microarray to accurately and
reliably indicate success in ChIP enrichment and library creation,
as well as provide a chromosome-scale overview of the eventual
deep sequencing information.
Figure 1. Mab-seq: Microarrays can be used to validate sequencing libraries in advance of deep sequencing. (A) Chromatin
immunoprecipitations are performed using standard techniques against either histone marks or site-specific transcription factors, followed by
generation of sequencing libraries. A small amount of these libraries are amplified, labeled with fluorophores, and hybridized to commercially
available microarrays. After the ChIP signal has been evaluated and passed quality control, the remaining library is deep-sequenced. (B) Direct
comparison of Hnf4a ChIP-seq (blue, absolute fragment count) and ChIP-chip (red, ratios for enrichment relative to whole-cell extract) data from the
same library across a 100 kb region in mouse hepatocytes. (C) ChIP-chip and ChIP-seq experimental data obtained from the same library show that
microarrays accurately predict a subset of sequencing-determined enriched regions, with few enriched regions unique to microarrays, consistent with
the greater depth and sensitivity of sequencing technologies.
doi:10.1371/journal.pone.0003713.g001
Mab-Seq
PLoS ONE | www.plosone.org 2 November 2008 | Volume 3 | Issue 11 | e3713Figure 2. The ability of sequencing to capture the complete set of microarray peaks is critically dependent on the depth of
sequencing employed. The cumulative fraction of microarray identified enriched regions captured by a given number of sequence reads is shown
as black (9 million), blue (6 million) and red (3 million), with the subset of reads that map to MmChr16, shown in parentheses. (A) Trimethylation of
the K4 position of histone H3, mainly found at transcription start sites, has reliably strong enrichment; thus, few reads are needed to identify
accurately the microarray-determined H3K4me3 enriched regions. In contrast, Hnf4a, as a site-specific transcription factor, requires substantially
greater numbers of reads to capture the microarray determined enriched regions. (B) Proportions of ChIP-seq enrichments that are shared with the
microarray (shared) or are ChIP-seq unique: narrow=not enough probes covered; repeat=no probes or too few probes due to repeat masking
during microarray probe design; and novel=enough probes covered but microarray signal not above threshold. (C) Table of different ChIP-seq
enrichments categories as in B. Number=count of ChIP-seq enrichment regions and the percentage of all (all, shared, unique) or the percentage of
unique (narrow, novel, repeat) shown in parentheses; Width=average width in bp; Enrich.=average fold enrichment over input. Note: The numbers
of shared ERs differs from the one shown in Figure 1C, because Figure 1C refers to the number of microarray ERs that overlap with sequencing ERs
whereas Figure 2C shows the number of sequencing ERs that overlap with microarray ERs. Hence if two sequencing ERs are identified that overlap
with a single microarray ER, this will count as one overlapping microarray ER in Figure 1C but as two overlapping sequencing ERs in this Figure (see
Methods for an explanation of how overlapping ERs are identified and counted).
doi:10.1371/journal.pone.0003713.g002
Mab-Seq
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serves not only to validate the efficacy of the Mab-seq library
preparation protocol, it can also be used as a practical gauge of
sequencing progress. Different ChIP libraries will require different
quantities of sequencing reads to adequately identify enriched
regions (Figure 2A, colored lines). While the total depth of
sequencing required may be calculated theoretically based on
degree of enrichment [12], determining the degree to which highly
enriched regions identified by the microarray have been identified
by sequencing reads may provide an empirical check that
adequate sequencing depth has been reached.
Sequencing increases the genomic coverage and
sensitivity of chromatin immunoprecipitations
As expected from prior reports, deep sequencing greatly
expands the number of identified ERs compared to microarrays
by virtue of increased sensitivity and interrogation of repeat-rich
regions [16]. Prior studies have compared matched, but not
identical, ChIP experiments on microarrays and sequencing
[12,13]. Here, we used the exact same sequencing libraries to
identify targets on microarrays and corresponding deep sequenc-
ing, providing matched data obtained from these two platforms
that are quantitatively comparable.
The enrichment levels of shared ERs (identified by both
microarray and sequencing analyses) are much higher than for those
identified only by sequencing. Figure 2C shows statistics for different
types of ERs, including shared regions identified by both ChIP-chip
and ChIP-seq, as well as ERs identified only by ChIP-seq. For the
histone modification H3K4me3, shared ERs have a mean
enrichment of 57-fold, compared to a mean 13-fold enrichment for
sequence-unique ERs (about four-fold increase), while for the
transcription factor Hnf4a, the shared ERs have a mean enrichment
of 23-fold, compared to 14-fold mean enrichment of sequencing-
unique ERs. For H3K4me3, in addition to the 191 ERs shared
between microarray and sequencing data, sequencing added an
additional 155 ERs that were not detected by microarray analysis
(Figure 1C). Similar results are found for the transcription factor
Hnf4a, where sequencing uniquely identifies an additional 311 ERs.
The majority of sequencing-unique ERs occur in regions where
the microarray does not have sufficient probes to confidently
identify enrichment (generally, at least three probes are required).
112 (72%) of the 155 sequencing-unique ERs identified for the
histone mark H3K4me3 are found in such regions of the mouse
Chr16 (MmChr16) microarray, as are 254 (82%) of the 311
sequencing-unique ERs for the transcription factor Hnf4a. These
can be further divided into two subclasses, attributable to two
factors: (i) the greater apparent sensitivity of HTP sequencing to
ERs spanning smaller numbers of base pairs (‘narrow’ in Figure 2),
and (ii) greater genomic coverage, especially in partially-repetitive
regions (‘repeat’ in Figure 2).
The first subclass (‘narrow’) consists of sequencing-unique peaks
that are due to the sensitivity limitations inherent in the microarray
design. ChIP-chip experiments interrogating ERs of narrow width
could be hindered by the combination of microarray design
parameters with analytic approaches that require co-voting of spaced
probes [2,6,7,9]; for instance, 60 base oligonucleotides with a 200–
300 base pair spacing are typical of many chromosomal tiling
approaches (e.g. Agilent whole genomemicroarrays).It ischallenging
to reliably identify ERs narrower than 400 bases using such a
microarray, as such regions will contain two or fewer probes. We
found that 36 (23%) of the 155 sequencing-unique ERs identified for
H3K4me3are400 base pairs or less in width and do not overlap with
at least three oligonucleotides present on the Agilent Chr16
microarray, as are 185 (60%) of the 311 sequencing-unique ERs
identified for Hnf4a. The greater number of lost peaks for the site-
specific transcription factor Hnf4a is likely due to the considerably
smaller mean width in bases of enrichment peaks versus H3K4me3
(508 bases versus 1213 bases). Many of these sequencing-unique
peaks can be seen as enrichments in the microarray data that span
only one or two neighboring probes, too few to confidently identify
ERs (see Figure 3). Other commercial microarray platforms (e.g.
Nimblegen and Affymetrix) with higher oligonucleotide densities may
have less sensitivity to signal fragmentation via probe loss.
For the second subclass (‘repeats’), enrichment in repetitive
regions account for 76 (49%) of the 155 sequencing-unique ERs
identified for H3K4me3 and 69 (22%) of 311 sequencing-unique
ERs for Hnf4a. Many of these previously undetectable enriched
regions show high enrichment (Figure 3). Because most commer-
cial microarrays share the early-design requirement of repeat-
masking before oligonucleotide selection, the majority of the
partially repetitive peaks would have been missed using any
oligonucleotide-based microarray.
The few remaining sequence-unique ERs are those for which
there is sufficient probe coverage on the microarray, but
insufficient sensitivity. The greater sensitivity of deep sequencing
enables the identification of ERs with levels of enrichment that,
while significant, are too low to be reliably identified via
microarray (Figures 2 and 3). These account for 28% of the
sequencing-unique ERs for the histone mark H3K4me3 and 18%
of the sequencing-unique ERs for the transcription factor Hnf4a.
The Mab-seq protocol allows the reliable detection of transcrip-
tionfactor bindingsites and modified histones usinga common pool
of ChIP-enriched DNA for microarray hybridization and deep
sequencing. Mab-seq provides excellent library validation prior to
sequencing, and thus can be used to compare different libraries for
experimental prioritization. Because ChIP sequencing library
creation is comparable in most aspects, including cost, to standard
ChIP-chip libraries, our methodology can be used to generate
valuable data and a validated collection of libraries in advance of
access to a next-generation sequencer. This method can immedi-
ately be applied to similar assays such as mapping of DNase
hypersensitivity sites, FAIRE and ChIP-SNP [12,17–19]. We have
found that the added cost of using proprietary library-building kits,
as opposed to previously described ligation mediated PCR and
whole genome amplification techniques [4,8,20], is somewhat offset
by the robust nature of the Illumina library procedure. An
additional and important advantage is the time saved in separate
sample preparation for distinctly different techniques.
Finally, we have used this technique to compare enriched regions
identified using microarrays with those identified by sequencing,
demonstrating that they agree on a core set of clearly identified
enrichedregions that canbe used to help gauge sequencing depth in
practice. We empirically demonstrate how, using the same ChIP
library, sequencing enables the identification of a larger set of
enriched regions, including regions with low density of microarray
probe coverage due to the narrowness of the region of enrichment
or the presence of repetitive elements that prevent unique
oligonucleotides from being placed on the microarray.
In summary, Mab-seq combines the relative ease and low-cost
of microarrays with the power and depth of HTP sequencing to
create flexible, quality-tested libraries that can be archived and re-
used multiple times.
Methods
Antibodies used: Hnf4a (sc-8987, Santa-Cruz) and H3K4me3
(ab8580, Abcam).
Mab-Seq
PLoS ONE | www.plosone.org 4 November 2008 | Volume 3 | Issue 11 | e3713Figure 3. Visualization of matched ChIP-chip and ChIP-seq data for Hnf4a. The four main categories (shared, narrow, novel, and repeat) are
described in detail in Figure 2. The x-axis spans 1 kb of mouse chromosome 16 and the y-axis shows the fold enrichment for the microarray data and
the depth of sequencing for the sequencing data. The threshold (3-fold) for the microarray-analysis is indicated as a grey line.
doi:10.1371/journal.pone.0003713.g003
Mab-Seq
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chip). Data accession number at NCBI Short Read Archive:
SRA001097 (ChIP-seq). The detailed Mab-seq experimental
protocol is included as a supplemental file (Methods S1). This
includes the detailed procedures for ChIP and library generation
for microarray hybridization and deep sequencing.
ChIP-chip microarray hybridization
Briefly, 1 mg of a reamplified ChIP-seq library was labeled with
Cyanine 5-dUTP and the input control was labeled with Cyanine 3-
dUTP (Enzo life sciences) using BioPrime Array CGH Genomic
Labeling System kit following the manufacturer’s protocol. Unincor-
porated dyes were removed using QIAquick PCR clean-up kit. Equal
amo u ntsofC y 5an dCy 3la b e le dD N Awasc om b in e dan dhy b r i d iz e d
at 65uC to microarrays using 26 Hi-RPM Hybridization Buffer
Gene expression and manufacturer’s protocols. After 40 hours
hybridization, arrays were washed with Agilent Array CGH wash
buffers 1 and 2 following the manufacturer’s protocol and scanned
using the Agilent scanner. Raw data was extracted using the Agilent
Feature Extraction Software, and processed as mentioned below.
ChIP-chip microarray analysis
The statistical analysis was performed using the limma package.
Quality of the arrays was assessed using array images of the
background and foreground intensities and also of the red/green
(Cy5/Cy3) ratios to check for spatial artifacts. A region was
considered enriched if it consisted of at least four probes, none of
which were more than 600 bases apart, with at least 66% of the
probes exhibiting enrichment over threshold. The threshold was
set at 5 for the H3K4me3 sample, and 3 for the Hnf4a sample.
These thresholds were determined empirically to enable the closest
correspondence to the ChIP-seq results. Additionally, regions were
enriched if they were not part of another enriched region and
consisted of either three probes (none more than 600 bases apart),
all of which were over the enrichment threshold, or of two probes
less than 600 bases apart, both over the enrichment threshold but
with no other probes within 600 bases. Base addresses for the
microarrays are based on the NCBI Build 36/mm8 (February
2006) assembly of the Mus musculus genome.
Identification of enriched regions using sequence data
Sequences were aligned to the NCBI Build 37/mm9 (July 2007)
assembly of the Mus musculus genome using Illumina Genome
Analyzer Pipeline Version 0.3.0 (Eland). Approximately 98% of the
sequences used in the analysis aligned uniquely with zero, one, or two
mismatches in the first 32 bases (see Table S1). The number of
aligned sequences for the input sample was 6,660,659 of which
89,064 aligned to the portion of mouse chromosome 16 region
covered by the microarray. For each treatment sample, 8,904,321
aligned reads were used, corresponding to 111,224 sequence reads in
the region covered by the microarray. The aligned sequences were
converted to coordinates on the NCBI Build 36/mm8 (February
2006) genome assembly using the DBAdaptor interface to Ensembl.
Enriched regions were identified according to a procedure similar to
that used by [11]. A region was considered enriched if it contained at
least 10 sequences, none separated by more than 100 bases, and the
total number of sequences in the region exhibited at least a 5-fold
enrichment over the number of sequences seen in the same region
from an input run. The set of enriched regions identified did not vary
considerably over a range of parameter settings.
Comparison and ranking of enriched regions
ERs were ranked by their mean enrichment values (mean fold
enrichment of probes for microarray-identified ERs, and fold
enrichment over input for sequencing-identified ERs). Using these
enrichment scores, we observed a greater dynamic range for
common enriched regions measured by sequencing over those
measured using microarrays (Figure S1).
Enriched regions identified using different techniques (micro-
array and sequencing) were considered to be shared if they
overlapped at least one base. For comparison purposes, overlap-
ping ERs were merged into single extended regions in a manner
similar to that discussed in [21]. In some cases, these merged
regions encompass differing numbers of sequencing-identified and
microarray-identified ERs, leading to the different numbers
reported for microarray-identified ERs also identified by sequenc-
ing versus sequencing-identified ERs also identified by microarray.
Supporting Information
Methods S1 Detailed Mab-seq Protocol for ChIP-seq and
ChIP-chip of the same library
Found at: doi:10.1371/journal.pone.0003713.s001 (0.20 MB
DOC)
Table S1 Mapping statistics of the sequencing reads used in this
study
Found at: doi:10.1371/journal.pone.0003713.s002 (1.33 MB TIF)
Figure S1 ChIP-seq exhibits greater effective dynamic range than
ChIP-chip. Enrichment scores for matched ERs are plotted using
the mean enrichment on the microarray and the fold enrichment
over Input for UHTP sequencing. The red lines indicate a linear
regression,withthe Pearson correlationcoefficientalsoreported.(A)
Enrichment values of ERs for trimethylation of the K4 position of
histone H3 have a more linear relationship (R=0.68), with the
effective fold range for microarrays ranging from 0 to 50, while
enrichment found by sequencing extend to 300-fold. (B) Range of
enrichment values for Hnf4a is more restricted, with a maximum of
approximately 18-fold on the microarray but still extended above
100-fold usingUHTP sequencing.Correlation of enrichment values
for Hnf4a using the two methods is relatively low (R=0.51)
compared to H3K4me3.
Found at: doi:10.1371/journal.pone.0003713.s003 (2.07 MB TIF)
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